Article
A Novel Melatonergic Signature Predicts Reccurence Risk and Therapeutic Response in Breast…
bioRxiv · 2018 · Hoa Quynh Tran
Key facts
| Title | A Novel Melatonergic Signature Predicts Reccurence Risk and Therapeutic Response in Breast Cancer Patients |
|---|---|
| First author | Hoa Quynh Tran |
| Journal | bioRxiv |
| Published | Nov 17, 2018 |
| DOI | 10.1101/472753 |
| Devices mentioned | K021312 |
| Product codes mentioned | KTT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1